Published in J Invest Dermatol on April 01, 2004
Langerhans cells cross-present antigen derived from skin. Proc Natl Acad Sci U S A (2006) 1.98
Layer-by-layer-assembled multilayer films for transcutaneous drug and vaccine delivery. ACS Nano (2009) 1.75
Expansion of antigen-specific regulatory T cells with the topical vitamin d analog calcipotriol. J Immunol (2009) 1.26
Cholera toxin activates nonconventional adjuvant pathways that induce protective CD8 T-cell responses after epicutaneous vaccination. Proc Natl Acad Sci U S A (2012) 0.85
Topical CpG adjuvantation of a protein-based vaccine induces protective immunity to Listeria monocytogenes. Clin Vaccine Immunol (2014) 0.77
Topical CpG Oligodeoxynucleotide Adjuvant Enhances the Adaptive Immune Response against Influenza A Infections. Front Immunol (2016) 0.75
Solid-in-oil nanodispersions for transdermal drug delivery systems. Biotechnol J (2016) 0.75
Psoriasis and pustular dermatitis triggered by TNF-{alpha} inhibitors in patients with rheumatologic conditions. Arch Dermatol (2007) 4.36
Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood. J Clin Invest (2003) 2.37
Topical resiquimod promotes priming of CTL to parenteral antigens. Vaccine (2009) 1.50
Usefulness of Interferon-γ release assays in the diagnosis of erythema induratum. Arch Dermatol (2011) 1.40
Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group. Blood (2007) 1.36
In situ beta cell death promotes priming of diabetogenic CD8 T lymphocytes. J Immunol (2002) 1.30
Expansion of antigen-specific regulatory T cells with the topical vitamin d analog calcipotriol. J Immunol (2009) 1.26
New concepts in antimalarial use and mode of action in dermatology. Dermatol Ther (2007) 1.24
Phagocytosis of apoptotic cells by macrophages from NOD mice is reduced. Diabetes (2002) 1.20
Optimization of epicutaneous immunization for the induction of CTL. Vaccine (2003) 1.19
Decidual NK cells alter in vitro first trimester extravillous cytotrophoblast migration: a role for IFN-gamma. J Immunol (2006) 1.17
Better influenza vaccines for older people: what will it take? J Infect Dis (2008) 1.17
Altered Toll-like receptor 9 responses in circulating B cells at the onset of extensive chronic graft-versus-host disease. Biol Blood Marrow Transplant (2007) 1.16
Liposome-encapsulated vincristine, vinblastine and vinorelbine: a comparative study of drug loading and retention. J Control Release (2005) 1.12
Pathophysiology of cutaneous lupus erythematosus. Clin Rev Allergy Immunol (2007) 1.11
TLR9 blockade inhibits activation of diabetogenic CD8+ T cells and delays autoimmune diabetes. J Immunol (2010) 1.09
Molecular markers of early-stage mycosis fungoides. J Invest Dermatol (2012) 1.04
Therapeutically optimized rates of drug release can be achieved by varying the drug-to-lipid ratio in liposomal vincristine formulations. Biochim Biophys Acta (2006) 1.04
Differences in body mass index among individuals with PsA, psoriasis, RA and the general population. Rheumatology (Oxford) (2011) 1.00
Tolerance induction by transcutaneous immunization through ultraviolet-irradiated skin is transferable through CD4+CD25+ T regulatory cells and is dependent on host-derived IL-10. J Immunol (2006) 1.00
Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models. Clin Cancer Res (2003) 0.98
Active vitamin D (1,25-dihydroxyvitamin D3) increases host susceptibility to Citrobacter rodentium by suppressing mucosal Th17 responses. Am J Physiol Gastrointest Liver Physiol (2012) 0.95
In vivo administration of liposomal vincristine sensitizes drug-resistant human solid tumors. Int J Cancer (2004) 0.94
Livedoid vasculopathy: an in-depth analysis using a modified Delphi approach. J Am Acad Dermatol (2013) 0.94
Topical CpG enhances the response of murine malignant melanoma to dacarbazine. J Invest Dermatol (2008) 0.93
Thymocyte selection-associated high mobility group box gene (TOX) is aberrantly over-expressed in mycosis fungoides and correlates with poor prognosis. Oncotarget (2014) 0.92
Reversible retiform purpura: a sign of cocaine use. CMAJ (2011) 0.92
Therapeutic integration of c-myc and bcl-2 antisense molecules with docetaxel in a preclinical model of hormone-refractory prostate cancer. Prostate (2007) 0.91
Characterization of the drug retention and pharmacokinetic properties of liposomal nanoparticles containing dihydrosphingomyelin. Biochim Biophys Acta (2007) 0.90
Synthetic methylated CpG ODNs are potent in vivo adjuvants when delivered in liposomal nanoparticles. Int Immunol (2009) 0.90
Treatment of atypical nevi with imiquimod 5% cream. Arch Dermatol (2007) 0.85
Antitumor efficacy of bcl-2 and c-myc antisense oligonucleotides in combination with cisplatin in human melanoma xenografts: relevance of the administration sequence. Clin Cancer Res (2005) 0.85
Role of c-myc protein in hormone refractory prostate carcinoma: cellular response to paclitaxel. Biochem Pharmacol (2004) 0.85
Psychiatric disorders in patients with immune-mediated inflammatory diseases: prevalence, association with disease activity, and overall patient well-being. J Rheumatol Suppl (2011) 0.85
Islet allograft rejection is independent of toll-like receptor signaling in mice. Transplantation (2009) 0.85
High efficiency entrapment of antisense oligonucleotides in liposomes. Methods Enzymol (2004) 0.83
IFN-gamma-mediated extravillous trophoblast outgrowth inhibition in first trimester explant culture: a role for insulin-like growth factors. Mol Hum Reprod (2008) 0.83
Chronic granulomatous disease with unusual clinical manifestation, outcome, and pattern of inheritance in an Iranian family. J Clin Immunol (2006) 0.83
Type 1 IFN-induced protein MxA and plasmacytoid dendritic cells in lesions of morphea. Exp Dermatol (2012) 0.83
Topical TLR9 agonists induce more efficient cross-presentation of injected protein antigen than parenteral TLR9 agonists do. Eur J Immunol (2007) 0.82
Murine models of cutaneous involvement in lupus erythematosus. Autoimmun Rev (2009) 0.82
Progression of spontaneous autoimmune diabetes is associated with a switch in the killing mechanism used by autoreactive CTL. Int Immunol (2004) 0.80
Antennapedia transduction sequence promotes anti tumour immunity to epicutaneously administered CTL epitopes. Vaccine (2004) 0.78
Inhibition of cathepsin S reduces allogeneic T cell priming but not graft-versus-host disease against minor histocompatibility antigens. Biol Blood Marrow Transplant (2011) 0.78
Skin immune responses to peptide and protein antigen are TLR4 independent. Cell Immunol (2003) 0.78
Decidual NK cell-derived conditioned medium (dNK-CM) mediates VEGF-C secretion in extravillous cytotrophoblasts. Am J Reprod Immunol (2011) 0.77
Topical CpG adjuvantation of a protein-based vaccine induces protective immunity to Listeria monocytogenes. Clin Vaccine Immunol (2014) 0.77
Atrophie blanche: is it associated with venous disease or livedoid vasculopathy? Adv Skin Wound Care (2014) 0.77
Tumor necrosis factor-a inhibition and palmoplantar pustulosis: Janus-faced therapy? J Rheumatol (2007) 0.77
Quality of life in patients with immune-mediated inflammatory diseases. J Rheumatol Suppl (2011) 0.77
Clinical and genetic registries in psoriatic disease. J Rheumatol (2008) 0.76
Combination Therapy With Tofacitinib and IL-12/23, IL-23, or IL-17A Inhibition for the Treatment of Refractory Psoriatic Arthritis: A Case Series. J Clin Rheumatol (2022) 0.75
Making necrotizing vasculitis simple. J Cutan Med Surg (2013) 0.75
Immunosuppression/Infections across Indications. Curr Probl Dermatol (2017) 0.75
Immune evasion strategies of pediatric precursor-B acute lymphoblastic leukemia after allogeneic bone marrow transplantation-a case study. Leuk Res (2005) 0.75